scholarly article | Q13442814 |
P2093 | author name string | Heng Zhu | |
Jianfei Hu | |||
Jiang Qian | |||
Jun Wan | |||
Jian Zhu | |||
Gangling Liao | |||
Meir Shamay | |||
S Diane Hayward | |||
Renfeng Li | |||
Hee-Sool Rho | |||
Crystal Woodard | |||
Ai Na Ng | |||
Rob Newman | |||
P2860 | cites work | Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA | Q24299259 |
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 | ||
Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes | Q24538878 | ||
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes | Q24673761 | ||
Diverse protein kinase interactions identified by protein microarrays reveal novel connections between cellular processes | Q27939657 | ||
KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA | Q28474913 | ||
Global analysis of protein phosphorylation in yeast | Q29615057 | ||
Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation | Q30435905 | ||
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation | Q30436561 | ||
Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication | Q30441657 | ||
A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences | Q33265370 | ||
KSHV-induced notch components render endothelial and mural cell characteristics and cell survival | Q33627013 | ||
Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 | ||
Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin | Q33781363 | ||
The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation | Q33834414 | ||
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes | Q33851443 | ||
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation | Q34130213 | ||
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 | ||
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells | Q34355092 | ||
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. | Q34531461 | ||
Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. | Q34648229 | ||
The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. | Q40318272 | ||
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 | ||
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. | Q40635358 | ||
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication | Q40644381 | ||
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. | Q40682995 | ||
Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation | Q41846091 | ||
Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen | Q41849965 | ||
The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains | Q41860564 | ||
Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus | Q41891421 | ||
Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. | Q42584460 | ||
Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies | Q42665921 | ||
ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection | Q42931199 | ||
The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus | Q57662902 | ||
The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility | Q84470156 | ||
Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection | Q34648384 | ||
Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins | Q34734774 | ||
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells | Q34976840 | ||
Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 | ||
Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest | Q35139294 | ||
The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence | Q35140238 | ||
Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53 | Q35252479 | ||
Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. | Q35635426 | ||
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. | Q35660314 | ||
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. | Q35664106 | ||
Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding | Q35785433 | ||
Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells. | Q35954902 | ||
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions. | Q36023151 | ||
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc | Q36099076 | ||
Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways | Q36454456 | ||
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 | ||
The MEK/ERK cascade: from signaling specificity to diverse functions | Q36656631 | ||
Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program | Q37060535 | ||
Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence | Q37157253 | ||
Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4 | Q37192108 | ||
Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling | Q37415666 | ||
Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity | Q38359214 | ||
Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores | Q39675686 | ||
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. | Q39700420 | ||
Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription | Q39711148 | ||
DNA-PK/Ku complex binds to latency-associated nuclear antigen and negatively regulates Kaposi's sarcoma-associated herpesvirus latent replication. | Q39725564 | ||
Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas | Q39744147 | ||
Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex | Q39749787 | ||
A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin | Q39756815 | ||
Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. | Q39794624 | ||
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation | Q39852047 | ||
Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. | Q39960021 | ||
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 | ||
ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication | Q40094006 | ||
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen | Q40169138 | ||
Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. | Q40176573 | ||
KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity | Q40286016 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | e1002972 | |
P577 | publication date | 2012-10-18 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | Phosphorylation of the chromatin binding domain of KSHV LANA | |
P478 | volume | 8 |
Q38721370 | A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18. |
Q35973676 | A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. |
Q30398275 | Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes |
Q30535717 | Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation |
Q37030691 | Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle |
Q64128205 | Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus |
Q38100381 | Epigenetic regulation of EBV and KSHV latency |
Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
Q35720026 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses |
Q92137391 | Infection-induced epigenetic changes and their impact on the pathogenesis of diseases |
Q34717723 | Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin. |
Q26738483 | Kaposi's Sarcoma Herpesvirus Genome Persistence |
Q27680411 | Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA |
Q35014918 | Molecular biology of KSHV lytic reactivation |
Q55437554 | Murine leukemia virus p12 tethers the capsid-containing pre-integration complex to chromatin by binding directly to host nucleosomes in mitosis. |
Q31040119 | PMD: A Resource for Archiving and Analyzing Protein Microarray data |
Q35680401 | Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication |
Q38100859 | Potential of protein kinase inhibitors for treating herpesvirus-associated disease. |
Q99591124 | Regulation of KSHV Latency and Lytic Reactivation |
Q21129297 | The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis |
Q38108700 | The chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |